Bristol Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bristol Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,100	Closed	-$473K	–	37
2018 Q4	$473K	Buy	+9,100	New	+$489K	0.57%	30

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bristol Advisors's BMY Position: Q1 2019 in Review

Bristol Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 9,100 shares — an estimated $473K sold.

Bristol Advisors first reported a position in BMY in Q4 2018 and held it in 1 quarter. The position peaked at $473K in Q4 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Bristol Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
Bristol Advisors sold 9,100 Bristol-Myers Squibb shares in Q1 2019, an estimated $473K.
Bristol Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 1 quarter.
Bristol Advisors's Bristol-Myers Squibb position peaked at $473K in Q4 2018.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Bristol Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.